Dottikon Es : Terms for Capital Increase

MEDIA RELEASE

Dottikon, February 26, 2021

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRA-LIA, CANADA, JAPAN, THE UNITED KINGDOM, OR THE EUROPEAN ECONOMIC AREA OR IN ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD NOT BE IN COMPLIANCE WITH APPLICABLE LAWS AND REGULATIONS.

DOTTIKON ES - Terms for Capital Increase

Dottikon, Switzerland, February 26, 2021 - DOTTIKON ES Group, positioned as strategic de-velopment and manufacturing partner and specialized in the area of hazardous reactions and the exclusive synthesis of active pharmaceutical ingredients (API) and fine chemicals, has pub-lished a media release on February 18, 2021, and announced a capital increase to realize further growth. The capital increase is aimed at financing parts of the expansion investments of around CHF 600 million during the next 7 years in new API production plants and infrastructure and the creation of over 200 new jobs in Production and Technology/Engineering at its Dottikon site (Aargau, Switzerland).

The terms for the announced capital increase are as follows

• ƒ Capital increase of up to 10 percent of the current share capital corresponding to up to 1'272'644 new registered shares at a nominal value of CHF 0.01 each

  • ƒ Existing shareholders are granted pre-emptive rights ƒ Subscription ratio: 10 to 1 ƒ Pre-emptive rights are non-tradeable

  • ƒ Registered shares for which the pre-emptive rights are not exercised will be placed on the market via bookbuilding ƒ Price range: CHF 160 to 195

  • ƒ Subscription price for existing shareholders corresponds with placement price for new shareholders

• ƒ Main shareholder Markus Blocher, CEO and President of the Board of Directors of DOTTIKON ES, will exercise up to 25 percent of his direct and indirect pre-emptive rights and will not go below a two-thirds majority share

• ƒ The step aims at increasing the free float of registered shares to over 21 percent, with the explicit goal of an SPI inclusion

• ƒ Net proceeds from the capital increase are expected at CHF 220.4 million (at an assumed subscription/placement price in the middle of the price range and issuance of the maximum number of new registered shares, minus estimated transaction costs and fees)

• ƒ The equity ratio immediately after the capital increase will remain over 80 percent

• ƒ Zürcher Kantonalbank acts as sole bookrunner and lead manager

Terms
Price range	CHF 160 to 195
Subscription ratio	10:1
Max. number of new registered shares	1'272'644
Expected net proceeds1	CHF 220.4 million
Symbol / Security no. / ISIN	DESN / 58258171 / CH0582581713
Security no. / ISIN pre-emptive rights	59635470 / CH0596354701

1 Assumed subscription/placement price in the middle of the price range and issuance of the maximum number of new registered shares, minus estimated transaction costs and fees

Indicative timetable
March 1, 2021, at close of trading	Cut-off date for the allocation of pre-emptive rights
March 2, 2021	Ex day Start of subscription period for new registered shares Start of bookbuilding for new registered shares for which the pre-emptive rights were not exercised
March 9, 2021, 12:00 noon	End of subscription period for new registered shares End of bookbuilding for registered shares for which pre-emptive rights were not exercised
March 10, 2021	Allocation of new registered shares from bookbuilding
March 12, 2021	First trading day and settlement date

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharma-ceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is spe-cialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthe-sis routes, improve selectivities, yields, and purities, and reduce waste. The versatile technology and equipment portfolio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes. DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development, clear and transparent data and process docu-mentation, and close customer communication.

DOTTIKON ES HOLDING AG is listed on the SIX Swiss Exchange. Symbol: DESN

Security number: 58258171 ISIN: CH0582581713

For further information please contact

Markus Blocher, Ph.D.

CEO

Dottikon ES Holding AG

Tel [phone] Fax [phone]

Disclaimer

This media release serves informational purposes and constitutes neither an offer to sell nor a solicitation or an advertisement to buy any shares of DOTTIKON ES HOLDING AG in any juris-diction. This media release does not constitute a prospectus within the meaning of Article 35 et seqq. of the Swiss Federal Act on Financial Services. Investors should base their decision to purchase or execute subscription rights or to purchase shares of DOTTIKON ES HOLDING AG exclusively on the official prospectus, which can be downloaded from the company's web-site (https://dottikon.com/dottikon-es-en/investors/capital-increase/) or will be available free of charge in electronic form at Zürcher Kantonalbank, IHKT, P.O. Box, 8010 Zurich, Switzerland (Tel: [phone]; email:[e-mail]). The shares described in the prospectus are publicly offered in Switzerland only. In addition, investors should seek advice from their bank or their financial adviser.

This media release and the information contained therein are not being issued in the United States of America, Australia, Canada, Japan, the United Kingdom, or the European Economic Area and must not be distributed within or to such countries or via publications with a general circulation in such countries.

This media release contains forward-looking statements such as projections, forecasts, and estimates. Such forward-looking statements are subject to certain risks and uncertainties which may cause actual results, performance, or events to differ materially from those anticipated in this media release. Readers should therefore not rely on these forward-looking statements. The forward-looking statements contained in this media release are based on the views and assump-tions of DOTTIKON ES HOLDING AG as of this date and DOTTIKON ES HOLDING AG does not assume any obligation to update or revise this media release.